Search research articles
Contact Us
Filters
Showing results (151-160 of 274) with videos related to
Page
of 28
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1983
Generation of antigen-specific suppressor cells in vitro in man
C Morimoto, E L Reinherz, R F Todd, et al.
Annals of the New York Academy of Sciences
|
January 1, 1988
Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue
R A Sobel, D A Hafler, E E Castro, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1988
The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions
R A Sobel, D A Hafler, E E Castro, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 15, 1992
CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions
K Sugita, T Hirose, D M Rothstein, et al.
European Journal of Immunology
|
February 1, 1991
Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture system
A Yamada, Y Nojima, K Sugita, et al.
British Journal of Cancer
|
August 6, 2009
CD26 expression on T cell lines increases SDF-1-alpha-mediated invasion
P A Havre, M Abe, Y Urasaki, et al.
Immunology
|
October 1, 1993
Protein kinase A-mediated phosphorylation of the T-cell surface antigen CD27
K Sugita, J D Dasgupta, Y Nojima, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 1991
Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes
Y Torimoto, N H Dang, E Vivier, et al.
Transplantation
|
May 27, 1994
The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation
K Sugita, R J Soiffer, C Murray, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1988
Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathway
C F Scott, J M Lambert, R S Kalish, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 274) with videos related to
Sort By:
Page
of 28
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1983
Generation of antigen-specific suppressor cells in vitro in man
C Morimoto, E L Reinherz, R F Todd, et al.
Annals of the New York Academy of Sciences
|
January 1, 1988
Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue
R A Sobel, D A Hafler, E E Castro, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1988
The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions
R A Sobel, D A Hafler, E E Castro, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 15, 1992
CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions
K Sugita, T Hirose, D M Rothstein, et al.
European Journal of Immunology
|
February 1, 1991
Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture system
A Yamada, Y Nojima, K Sugita, et al.
British Journal of Cancer
|
August 6, 2009
CD26 expression on T cell lines increases SDF-1-alpha-mediated invasion
P A Havre, M Abe, Y Urasaki, et al.
Immunology
|
October 1, 1993
Protein kinase A-mediated phosphorylation of the T-cell surface antigen CD27
K Sugita, J D Dasgupta, Y Nojima, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 1991
Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes
Y Torimoto, N H Dang, E Vivier, et al.
Transplantation
|
May 27, 1994
The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation
K Sugita, R J Soiffer, C Murray, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1988
Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathway
C F Scott, J M Lambert, R S Kalish, et al.
Page
of 28